| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26179-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26226-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26174-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-54307-100ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26674-50ul | |||
![Flow Cytometry: KLRG1 Antibody (8E11) [NBP3-26179] - Overlay Peak curve showing A549 cells stained with KLRG1 Antibody (8E11) (red line) at 1:100. The cells were incubated in 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26179_rabbit-klrg1-mab-8e11-282202414312743.jpg "Flow Cytometry: KLRG1 Antibody (8E11) [NBP3-26179] - Overlay Peak curve showing A549 cells stained with KLRG1 Antibody (8E11) (red line) at 1:100. The cells were incubated in 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.")
![Flow Cytometry: HLA G Antibody (17A5) [NBP3-26226] - Overlay Peak curve showing U937 cells stained with HLA G Antibody (17A5) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26226_rabbit-hla-g-mab-17a5-282202414183662.jpg "Flow Cytometry: HLA G Antibody (17A5) [NBP3-26226] - Overlay Peak curve showing U937 cells stained with HLA G Antibody (17A5) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.")
![Flow Cytometry: Plastin L Antibody (29G10) [NBP3-26174] - Overlay Peak curve showing RAJI cells stained with Plastin L Antibody (29G10) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26174_rabbit-plastin-l-mab-29g10-282202414183650.jpg "Flow Cytometry: Plastin L Antibody (29G10) [NBP3-26174] - Overlay Peak curve showing RAJI cells stained with Plastin L Antibody (29G10) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.")
![ELISA: Mouse IL-12 ELISA Kit (Colorimetric) [NBP1-92658] - IL-12 ELISA Kit (Colorimetric) [NBP1-92658] - Representative standard curve for mouse IL-12 ELISA. Mouse IL- 12 was diluted in serial 2-fold steps in sample diluent. Do not use this standard curve to derive test results. A standard curve must be run for each group ofmicrowell strips assayed.](http://images.novusbio.com/fullsize/Mouse-IL-12-ELISA-Kit-Colorimetric-ELISA-NBP1-92658-img0002.jpg "ELISA: Mouse IL-12 ELISA Kit (Colorimetric) [NBP1-92658] - IL-12 ELISA Kit (Colorimetric) [NBP1-92658] - Representative standard curve for mouse IL-12 ELISA. Mouse IL- 12 was diluted in serial 2-fold steps in sample diluent. Do not use this standard curve to derive test results. A standard curve must be run for each group ofmicrowell strips assayed.")
![ELISA: Monkey IL-10 ELISA Kit (Colorimetric) [NBP1-92708]](http://images.novusbio.com/fullsize/Primate-IL-10-ELISA-Kit-Colorimetric-ELISA-NBP1-92708-img0001.jpg "ELISA: Monkey IL-10 ELISA Kit (Colorimetric) [NBP1-92708]")
![ELISA: CD96 Antibody (4A4) [NBP3-26674] - The Binding Activity of CD96 with CD96 Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized Human CD96 at 2 ug/mL can bind CD96 Antibody, the EC50 is 95.78-127.1 ng/mL.](http://images.novusbio.com/fullsize/nbp3-26674_human-cd96-mab-4a4-262202412272344.jpg "ELISA: CD96 Antibody (4A4) [NBP3-26674] - The Binding Activity of CD96 with CD96 Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized Human CD96 at 2 ug/mL can bind CD96 Antibody, the EC50 is 95.78-127.1 ng/mL.")